Top Buy
| Security | Buy | Sell ▼ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Pfizer Inc. | 27 | 5 | 0 | 1 | €26.47 | €40.66 | 53.606% |
| Agilent Technologies Inc. | 14 | 4 | 4 | 1 | €123.12 | €131.48 | 6.794% |
| Universal Health Services B | 9 | 3 | 2 | 0 | €174.00 | €167.76 | -3.585% |
| Vertex Pharmaceuticals Inc. | 47 | 2 | 4 | 0 | €447.40 | €428.30 | -4.269% |
| Align Technology | 15 | 2 | 0 | 0 | €236.60 | €345.95 | 46.217% |
| Incyte Corp. | 12 | 2 | 0 | 0 | €54.76 | €78.42 | 43.211% |
| Edwards Lifesciences Corp. | 27 | 1 | 2 | 0 | €81.62 | €88.17 | 8.024% |
| Merck & Co. Inc. | 30 | 1 | 2 | 0 | €121.00 | €124.97 | 3.284% |
| Zoetis Inc. A | 23 | 1 | 0 | 0 | €163.56 | €200.06 | 22.314% |
| UnitedHealth Group Inc. | 35 | 1 | 4 | 0 | €454.30 | €542.36 | 19.384% |
| Johnson & Johnson | 33 | 1 | 3 | 0 | €136.16 | €195.31 | 43.439% |
| Regeneron Pharmaceuticals Inc. | 37 | 1 | 3 | 0 | €928.40 | €962.84 | 3.710% |
| Biogen Inc. | 50 | 1 | 5 | 0 | €208.80 | €293.22 | 40.433% |
| Henry Schein Inc. | 12 | 1 | 0 | 0 | €63.44 | €79.48 | 25.282% |
| Hologic Inc. | 17 | 0 | 1 | 0 | €68.50 | €84.52 | 23.388% |
| Boston Scientific | 49 | 0 | 4 | 0 | €71.50 | €73.64 | 2.992% |
| Idexx Laboratories Inc. | 12 | 0 | 1 | 0 | €460.50 | €550.70 | 19.588% |
| Eli Lilly Corp. | 50 | 0 | 4 | 0 | €787.20 | €787.65 | 0.057% |
| Abbott Laboratories | 18 | 0 | 2 | 0 | €99.61 | €116.48 | 16.936% |
| Cigna Corp. | 18 | 0 | 3 | 0 | €313.05 | €345.35 | 10.316% |
| Intuitive Surgical Inc | 34 | 0 | 0 | 0 | €386.75 | €391.89 | 1.328% |
| Becton, Dickinson & Co. | 9 | 0 | 0 | 0 | €222.80 | €268.91 | 20.694% |
| Laboratory Corp. Of America (labcorp) | 12 | 0 | 1 | 0 | €197.00 | €237.30 | 20.458% |
| Teleflex Inc. | 9 | 0 | 0 | 0 | €197.00 | €245.97 | 24.856% |
| Thermo Fisher Scientific Inc. | 27 | 0 | 1 | 0 | €537.90 | €568.09 | 5.613% |